BridgeMD
New treatment option for Old Age; Debility
Official title Combined Effects of NMES and LIRT on Muscle Strength, Girth, and Physical Endurance in the Geriatric Population
ClinicalTrials.gov ID: NCT07646405
What this study is testing
- What it's testing
- This study will employ a randomized controlled trial design with a pre-post design to investigate the combined effects of Neuromuscular Electrical Stimulation (NMES) and Low-Intensity Resistance Training (LIRT) on muscle strength, muscle girth, and physical endurance in the geriatric population. Participants will be randomly assigned to either an intervention group or a control group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 to 85
You may be able to join if
- Age: 65 to 85 (35)
- Both male and female will be added(29)
- Patients with low calf muscle mass \<31.5 cm for females and \<33.5 cm for males will be included in this study(36).
- Participants able to complete the Five Times Sit-to-Stand Test in ≤ 10 seconds (men) or ≤ 11 seconds (women)(37).
- Participants must have ability to walk independently and absence of severe medical conditions(29).
You likely can't join if
- Participants with contraindications to NMES or RT, such as pacemakers or severe cardiovascular disease(29).
- Participants with a MoCA score of less than 26 will be excluded to ensure adequate cognitive ability to comprehend and follow the study protocol...
- Participants with any musculoskeletal issues will be excluded from this study(35).
- Participants with neuromuscular disorders that may affect muscle strength or function(29).
See the full eligibility criteria
- Age: 65 to 85 (35)
- Both male and female will be added(29)
- Patients with low calf muscle mass \<31.5 cm for females and \<33.5 cm for males will be included in this study(36).
- Participants able to complete the Five Times Sit-to-Stand Test in ≤ 10 seconds (men) or ≤ 11 seconds (women)(37).
- Participants must have ability to walk independently and absence of severe medical conditions(29).
- Participants who takes \> 12 seconds to complete TUG will be included in this study(38
- Participants with contraindications to NMES or RT, such as pacemakers or severe cardiovascular disease(29).
- Participants with a MoCA score of less than 26 will be excluded to ensure adequate cognitive ability to comprehend and follow the study protocol, including exercise and neuromuscular stimulation procedures (39).
- Participants with any musculoskeletal issues will be excluded from this study(35).
- Participants with neuromuscular disorders that may affect muscle strength or function(29).
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.